First Aid Only Lidocaine Hydrochloride Analgesic Burn Gel
FDA Label NDC 0924-5004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Acme United Corporation for the product First Aid Only Lidocaine Hydrochloride Analgesic Burn Gel (NDC 0924-5004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, use, warnings, do not use, stop use and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Facts

Drug Facts

Active Ingredient

Lidocaine Hydrochloride 2%

Purpose

External Analgesic

Use

for the temporary relief of pain associated with • minor burns

Warnings

For external use only

Avoid Contact with eyes

Do Not Use

• on wounds or damaged skin • in large quantities, particularly over raw surfaces or blistered areas

Stop Use And Ask A Doctor If

• condition worsens or symptoms persist for more than 7 days • symptoms clear up and occur again within a few days

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

• adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily • children under 2 years of age: do not use consult a doctor

Other Information

•store at room temperature 15-30°C (59-86°F)

Inactive Ingredients

acrylates/C10-30 alkyl acrylate crosscopolymer, carbomer, glycerin, imidurea, methylparaben, propylene glycol, propylparaben, purified water, tea tree oil, trolamine

Questions?

800-835-2263

Package Labeling:

Carton Label (807113 001 Reva Fda)

Carton Label (807113 001 Reva Fda)

* Please review the disclaimer below.